PH Aerospace super-cycle (commercial OEM +22% organic, record $12.5B total backlog) compounds at 14%+ EPS growth with 29.5% segment margins, while the diversified industrial portfolio provides downside cushion via aftermarket/service revenue and the Win Strategy drives structural margin expansion across all segments.
Conviction●●●○○3 of 5
Research target1162.99Snapshot target
Thesis statusNEEDS_MORE_DATALast reviewed 6/22/26
Market cap121.18BSnapshot value
(1) Aerospace segment delivering 29.5% operating margins with +14% organic growth — multi-year backlog visibility from Boeing/Airbus production ramps + defense spending. (2) $9.25B Filtration Group acquisition adds high-margin aftermarket revenue — accretive to margins and reduces cyclicality. (3) CIRCOR Aerospace acquisition strengthens defense motion/control position. FY2026 EPS guidance raised to $31.20.
(1) Boeing/Airbus production rate cuts — PH's commercial OEM exposure (~22% of Aerospace growth) reverses if airframers slow below planned rates. (2) $9.25B Filtration Group acquisition integration fails or proves overpriced — large bet that could impair returns. (3) Industrial recession — diversified industrial segments still ~60% of revenue and cyclical; a sharp downturn hits earnings even as Aerospace holds up.
Strongly bullish — "best-in-class execution" and "Win Strategy" margin expansion consistently praised. Aerospace super-cycle thesis widely accepted with record backlog as evidence. 11% dividend increase + buybacks signal management confidence. Concern about acquisition integration risk and whether 20%+ Aerospace growth can sustain. High institutional ownership and analyst conviction — rarely cited as overvalued.
Snapshot · 6/22/26🟡 Mixed · 13F 11+/14- · short↓0.24
Snapshot · 6/22/26